Want to see NASC full AI Analyst Report?
Total Valuation
Nascent Pharma Holdings has a market cap or net worth of $2.13M. The enterprise value is $9.54M.
Market Cap$2.13M
Enterprise Value$9.54M
Share Statistics
Nascent Pharma Holdings has 142,229,160 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding142,229,160
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Nascent Pharma Holdings’s return on equity (ROE) is 0.80 and return on invested capital (ROIC) is 107.66%.
Return on Equity (ROE)0.80
Return on Assets (ROA)-34.06
Return on Invested Capital (ROIC)107.66%
Return on Capital Employed (ROCE)0.37
Revenue Per Employee0.00
Profits Per Employee-814.70K
Employee Count12
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Nascent Pharma Holdings is ―. Nascent Pharma Holdings’s PEG ratio is 0.00269.
PE Ratio―
PS Ratio0.00
PB Ratio-0.16
Price to Fair Value-0.16
Price to FCF-9.39
Price to Operating Cash Flow-5.66
PEG Ratio0.00269
Income Statement
In the last 12 months, Nascent Pharma Holdings had revenue of 0.00 and earned -10.20M in profits. Earnings per share was -0.17.
Revenue0.00
Gross Profit-742.32K
Operating Income-4.76M
Pretax Income-9.78M
Net Income-10.20M
EBITDA-7.65M
Earnings Per Share (EPS)-0.17
Cash Flow
In the last 12 months, operating cash flow was 246.61K and capital expenditures 0.00, giving a free cash flow of 246.61K billion.
Operating Cash Flow246.61K
Free Cash Flow246.61K
Free Cash Flow per Share<0.01
Dividends & Yields
Nascent Pharma Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.64
52-Week Price Change-39.13%
50-Day Moving Average0.01
200-Day Moving Average0.02
Relative Strength Index (RSI)39.89
Average Volume (3m)35.25K
Important Dates
Nascent Pharma Holdings upcoming earnings date is May 28, 2024, TBA (Confirmed).
Last Earnings DateMay 30, 2023
Next Earnings DateMay 28, 2024
Ex-Dividend Date―
Financial Position
Nascent Pharma Holdings as a current ratio of 0.02, with Debt / Equity ratio of -66.71%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap3.99
Net Debt to EBITDA-1.08
Interest Coverage Ratio-2.68
Taxes
In the past 12 months, Nascent Pharma Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Nascent Pharma Holdings EV to EBITDA ratio is -1.36, with an EV/FCF ratio of -46.83.
EV to Sales0.00
EV to EBITDA-1.36
EV to Free Cash Flow-46.83
EV to Operating Cash Flow-46.83
Balance Sheet
Nascent Pharma Holdings has $7.88K in cash and marketable securities with $9.01M in debt, giving a net cash position of -$9.01M billion.
Cash & Marketable Securities$7.88K
Total Debt$9.01M
Net Cash-$9.01M
Net Cash Per Share-$0.06
Tangible Book Value Per Share-$0.22
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Nascent Pharma Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―